AAAAAA
Results: 1-25/27
Authors:
JIRHOLT P
OHLIN M
BORREBAECK CAK
SODERLIND E
Citation: P. Jirholt et al., EXPLOITING SEQUENCE SPACE - SHUFFLING IN-VIVO FORMED COMPLEMENTARITY-DETERMINING REGIONS INTO A MASTER FRAMEWORK, Gene, 215(2), 1998, pp. 471-476
Authors:
EICKMANN M
LANGE R
OHLIN M
RESCHKE M
RADSAK K
Citation: M. Eickmann et al., EFFECT OF CYSTEINE SUBSTITUTIONS ON DIMERIZATION AND INTERFRAGMENT LINKAGE OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-B (GP-UL55), Archives of virology, 143(10), 1998, pp. 1865-1880
Authors:
OHLIN M
BORREBAECK CAK
Citation: M. Ohlin et Cak. Borrebaeck, INSERTIONS AND DELETIONS IN HYPERVARIABLE LOOPS OF ANTIBODY HEAVY-CHAINS CONTRIBUTE TO MOLECULAR DIVERSITY, Molecular immunology, 35(4), 1998, pp. 233-238
Authors:
STRANDH M
OHLIN M
BORREBAECK CAK
OHLSON S
Citation: M. Strandh et al., NEW APPROACH TO STEROID SEPARATION BASED ON A LOW-AFFINITY IGM ANTIBODY, Journal of immunological methods, 214(1-2), 1998, pp. 73-79
Authors:
OHLIN M
SILVESTRI M
SUNDQVIST VA
BORREBAECK CAK
Citation: M. Ohlin et al., CYTOMEGALOVIRUS GLYCOPROTEIN B-SPECIFIC ANTIBODY ANALYSIS USING ELECTROCHEMILUMINESCENCE DETECTION-BASED TECHNIQUES, Clinical and diagnostic laboratory immunology, 4(1), 1997, pp. 107-111
Authors:
FUREBRING C
OHLIN M
PETTERSSON S
BORREBAECK CAK
Citation: C. Furebring et al., EVALUATION OF NOVEL CONTROL ELEMENTS BY CONSTRUCTION OF EUKARYOTIC EXPRESSION VECTORS, Gene, 188(2), 1997, pp. 191-198
Authors:
NILSSON N
WALLENOHMAN M
OHLIN M
BORREBAECK CAK
Citation: N. Nilsson et al., ALTERED GENE-EXPRESSION ASSOCIATED WITH APOPTOSIS IN A PRE-B-LEUKEMICCELL-LINE FOLLOWING CROSS-LINKING OF MHC CLASS-I, Experimental cell research, 231(1), 1997, pp. 190-197
Authors:
OHLIN M
BORREBAECK CAK
Citation: M. Ohlin et Cak. Borrebaeck, LOW-AFFINITY, ANTIBODY-BINDING OF AN ESCHERICHIA COLI-DERIVED COMPONENT, FEMS immunology and medical microbiology, 13(2), 1996, pp. 161-168
Authors:
OHLIN M
BORREBAECK CAK
Citation: M. Ohlin et Cak. Borrebaeck, CHARACTERISTICS OF HUMAN-ANTIBODY REPERTOIRES FOLLOWING ACTIVE IMMUNE-RESPONSES IN-VIVO, Molecular immunology, 33(7-8), 1996, pp. 583-592
Authors:
DUENAS M
MALMBORG AC
CASALVILLA R
OHLIN M
BORREBAECK CAK
Citation: M. Duenas et al., SELECTION OF PHAGE DISPLAYED ANTIBODIES BASED ON KINETIC CONSTANTS, Molecular immunology, 33(3), 1996, pp. 279-285
Authors:
OHLIN M
OWMAN H
MACH M
BORREBAECK CAK
Citation: M. Ohlin et al., LIGHT-CHAIN SHUFFLING OF A HIGH-AFFINITY ANTIBODY RESULTS IN A DRIFT IN EPITOPE RECOGNITION, Molecular immunology, 33(1), 1996, pp. 47-56
Authors:
SCHOPPEL K
HASSFURTHER E
BRITT W
OHLIN M
BORREBAECK CAK
MACH M
Citation: K. Schoppel et al., ANTIBODIES SPECIFIC FOR THE ANTIGENIC DOMAIN-1 OF GLYCOPROTEIN-B (GPUL55) OF HUMAN CYTOMEGALOVIRUS BIND TO DIFFERENT SUBSTRUCTURES, Virology, 216(1), 1996, pp. 133-145
Authors:
MALMBORG AC
DUENAS M
OHLIN M
SODERLIND E
BORREBAECK CAK
Citation: Ac. Malmborg et al., SELECTION OF BINDERS FROM PHAGE DISPLAYED ANTIBODY LIBRARIES USING THE BIACORE(TM) BIOSENSOR, Journal of immunological methods, 198(1), 1996, pp. 51-57
Authors:
BOLD S
OHLIN M
GARTEN W
RADSAK K
Citation: S. Bold et al., STRUCTURAL DOMAINS INVOLVED IN HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B-MEDIATED CELL-CELL FUSION, Journal of General Virology, 77, 1996, pp. 2297-2302
Authors:
DUENAS M
CHIN LT
MALMBORG AC
CASALVILLA R
OHLIN M
BORREBAECK CAK
Citation: M. Duenas et al., IN-VITRO IMMUNIZATION OF NAIVE HUMAN B-CELLS YIELDS HIGH-AFFINITY IMMUNOGLOBULIN-G ANTIBODIES AS ILLUSTRATED BY PHAGE DISPLAY, Immunology, 89(1), 1996, pp. 1-7
Authors:
ANDERSSON E
DAHLENBORG K
OHLIN M
BORREBAECK CAK
CARLSSON R
Citation: E. Andersson et al., IMMUNOGLOBULIN PRODUCTION INDUCED BY CD57(-DERIVED HELPER T-CELLS IN-VITRO REQUIRES ADDITION OF EXOGENOUS IL-2() GC), Cellular immunology, 169(2), 1996, pp. 166-173
Authors:
OHLIN M
PLACHTER B
SUNDQVIST VA
STEENBAKKERS PGA
MIDDELDORP JM
BORREBAECK CAK
Citation: M. Ohlin et al., HUMAN-ANTIBODY REACTIVITY AGAINST THE LOWER MATRIX PROTEIN (PP65) PRODUCED BY CYTOMEGALOVIRUS, Clinical and diagnostic laboratory immunology, 2(3), 1995, pp. 325-329
Authors:
DUENAS M
AYALA M
VAZQUEZ J
OHLIN M
SODERLIND E
BORREBAECK CAK
GAVILONDO JV
Citation: M. Duenas et al., A POINT MUTATION IN A MURINE IMMUNOGLOBULIN V-REGION STRONGLY INFLUENCES THE ANTIBODY YIELD IN ESCHERICHIA-COLI, Gene, 158(1), 1995, pp. 61-66
Authors:
WINGREN C
HANSSON UB
MAGNUSSON CGM
OHLIN M
Citation: C. Wingren et al., ANTIGEN-BINDING SITES DOMINATE THE SURFACE-PROPERTIES OF IGG ANTIBODIES, Molecular immunology, 32(11), 1995, pp. 819-827
Authors:
ANDERSSON E
OHLIN M
BORREBAECK CAK
CARLSSON R
Citation: E. Andersson et al., CD4(-CELLS DERIVED FROM PERIPHERAL-BLOOD DO NOT SUPPORT IMMUNOGLOBULIN PRODUCTION BY B-CELLS()CD57(+) T), Cellular immunology, 163(2), 1995, pp. 245-253
Authors:
DUENAS M
VAZQUEZ J
AYALA M
SODERLIND E
OHLIN M
PEREZ L
BORREBAECK CAK
GAVILONDO JV
Citation: M. Duenas et al., INTRACELLULAR AND EXTRACELLULAR EXPRESSION OF AN SCFV ANTIBODY FRAGMENT IN ESCHERICHIA-COLI - EFFECT OF BACTERIAL STRAINS AND PATHWAY ENGINEERING USING GROES L CHAPERONINS/, BioTechniques, 16(3), 1994, pp. 476
Authors:
OHLIN M
OWMAN H
RIOUX JD
NEWKIRK MM
BORREBAECK CAK
Citation: M. Ohlin et al., RESTRICTED VARIABLE REGION GENE USAGE AND POSSIBLE RHEUMATOID-FACTOR RELATIONSHIP AMONG HUMAN MONOCLONAL-ANTIBODIES SPECIFIC FOR THE AD-1 EPITOPE ON CYTOMEGALOVIRUS GLYCOPROTEIN-B, Molecular immunology, 31(13), 1994, pp. 983-991
Authors:
HARDY E
OHLIN M
LLANO M
Citation: E. Hardy et al., ENHANCED ELISA SENSITIVITY USING TCA FOR EFFICIENT COATING OF BIOLOGICALLY-ACTIVE LIPOPOLYSACCHARIDES OR LIPID-A TO THE SOLID-PHASE, Journal of immunological methods, 176(1), 1994, pp. 111-116
Authors:
OHLIN M
BORREBAECK CAK
Citation: M. Ohlin et Cak. Borrebaeck, FLOW CYTOMETRIC ANALYSIS OF THE STABILITY OF ANTIBODY-PRODUCTION BY HUMAN X HUMAN X MOUSE HETEROHYBRIDOMA SUBCLONES, Journal of immunological methods, 170(1), 1994, pp. 75-82
Authors:
CHIN LT
HINKULA J
LEVI M
OHLIN M
WAHREN B
BORREBAECK CAK
Citation: Lt. Chin et al., SITE-DIRECTED PRIMARY IN-VITRO IMMUNIZATION - PRODUCTION OF HIV-1 NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES FROM LYMPHOCYTES OBTAINED FROM SERONEGATIVE DONORS, Immunology, 81(3), 1994, pp. 428-434